The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect

被引:22
作者
Lemmens, Kristien J. A. [1 ]
van de Wier, Bregje [1 ]
Vaes, Nathalie [1 ]
Ghosh, Mitrajit [2 ]
van Zandvoort, Marc A. M. J. [2 ]
van der Vijgh, Wim J. F. [1 ]
Bast, Aalt [1 ]
Haenen, Guido R. M. M. [1 ]
机构
[1] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Toxicol, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands
关键词
7-Mono-O-(beta-hydroxyethyl)-rutoside; monoHER; Flavonoid; Antioxidant; Site specific scavenging; DOXORUBICIN-INDUCED CARDIOTOXICITY; MONOHYDROXYETHYLRUTOSIDE; MONOHER; DAMAGE;
D O I
10.1016/j.tiv.2013.12.019
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The flavonoid 7-mono-O-(beta-hydroxyethyl)-rutoside (monoHER) is an effective protector against doxorubicin induced toxicity which has been related to the antioxidant activity of monoHER. The present study examines the potential relevance of the direct scavenging activity of the flavonoid. The potency of the direct antioxidant effect was confirmed by its instantaneous protection against intracellular oxidative stress in human umbilical vein endothelial cells at therapeutically achievable concentrations (EC50= 60 nM) underpinning the involvement of a direct scavenging activity. This direct effect of monoHER is substantiated by (i) its site specific scavenging effect, i.e. on a molecular level monoHER is positioned at the location of radical formation, (ii) its position in the antioxidant network, i.e. on a biochemical level oxidized monoHER quickly reacts with ascorbate or glutathione, (iii) its location in the vascular system, i.e. on a cellular level monoHER is localized in the endothelial and smooth muscle cells in the vascular wall. It is concluded that the flavonoid monoHER can display a physiologically important direct antioxidant effect. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 34 条
[1]   Protectors against doxorubicin-induced cardiotoxicity:: Flavonoids [J].
Bast, A. ;
Kaiserova, H. ;
den Hartog, G. J. M. ;
Haenen, G. R. M. M. ;
van der Vijgh, W. J. F. .
CELL BIOLOGY AND TOXICOLOGY, 2007, 23 (01) :39-47
[2]   OXIDANTS AND ANTIOXIDANTS - STATE-OF-THE-ART [J].
BAST, A ;
HAENEN, GRMM ;
DOELMAN, CJA .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S2-S13
[3]   The toxicity of antioxidants and their metabolites [J].
Bast, A ;
Haenen, GRMM .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2002, 11 (3-4) :251-258
[4]   Ten misconceptions about antioxidants [J].
Bast, Aalt ;
Haenen, Guido R. M. M. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (08) :430-436
[5]   The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice [J].
Bruynzeel, Anna M. E. ;
Mul, Paula P. N. ;
Berkhof, Johannes ;
Bast, Aalt ;
Niessen, Hans W. M. ;
van der Vijgh, Wim J. F. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) :699-702
[6]   Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences [J].
Cai, H .
CARDIOVASCULAR RESEARCH, 2005, 68 (01) :26-36
[7]   Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: Improvement with Venoruton [J].
Cesarone, MR ;
Belcaro, G ;
Pellegrini, L ;
Ledda, A ;
Vinciguerra, G ;
Ricci, A ;
Gizzi, G ;
Ippolito, E ;
Fano, F ;
Dugall, M ;
Acerbi, G ;
Cacchio, M ;
Di Renzo, A ;
Hosoi, M ;
Stuard, S ;
Corsi, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (01) :93-98
[8]   Functional food science and defence against reactive oxidative species [J].
Diplock, AT ;
Charleux, JL ;
Crozier-Willi, G ;
Kok, FJ ;
Rice-Evans, C ;
Roberfroid, M ;
Stahl, W ;
Viña-Ribes, J .
BRITISH JOURNAL OF NUTRITION, 1998, 80 :S77-S112
[9]  
Ehrlich P, 1913, BRIT MED J, V1913, P353
[10]   Significance of Dietary Antioxidants for Health [J].
Gordon, Michael H. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (01) :173-179